TABLE 2

Maximal responses (Emax) and potency (pEC50) values derived from concentration–response curves to BAY 41-2272 (0.0001–30 μM) and BAY 60-2770 (0.0001–30 μM) in urethra smooth muscle from lean and obese mice in the presence and absence of 1H-[1,2,4] oxadiazolo [4,3-a]quinoxalin-1-one (ODQ; 10 μM)

Data are presented as mean ± S.E.M. (n = 4–8). Values of Emax are represented as percentage.

GroupBAY 41-2272BAY 60-2770
EmaxpEC50EmaxpEC50
%%
Lean75.9 ± 2.36.65 ± 0.0541.9 ± 2.77.19 ± 0.08
Obese60.9 ± 0.5a6.46 ± 0.0663.4 ± 4.0b7.75 ± 0.07a
Lean + ODQ54.4 ± 3.9b6.91 ± 0.0759.7 ± 0.4a7.33 ± 0.04
Obese + ODQ42.0 ± 3.5c6.49 ± 0.0872.7 ± 5.97.24 ± 0.08
  • a P < 0.05 compared with respective untreated lean group.

  • b P < 0.01 compared with respective untreated lean group.

  • c P < 0.01 compared with obese group (ANOVA followed by a Tukey test).